Chloroquine-resistant <it>Plasmodium vivax </it>malaria in Debre Zeit, Ethiopia

Chloroquine-resistant <it>Plasmodium vivax </it>malaria in Debre Zeit, Ethiopia

<p>Abstract</p> <p>Background</p> <p><it>Plasmodium vivax </it>accounts for about 40% of all malaria infection in Ethiopia. Chloroquine (CQ) is the first line treatment for confirmed <it>P. vivax </it>malaria in the country. The first report of C...

Full description

Bibliographic Details
Main Authors: Muchohi Simon, Elhassan Ibrahim, Tesfaye Gezahegn, Yamuah Lawrence, Petros Beyene, Teka Hiwot, Kokwaro Gilbert, Aseffa Abraham, Engers Howard
Format: Article
Language:English
Published: BMC 2008-10-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/7/1/220

Similar Items

Similar Items